Combined heart and liver transplantation on cardiopulmonary bypass: Report of four cases

Canadian Journal of Anesthesia

Volumn 57, Issue 4, 2010, Pages 355-360

  Hennessey, Trevor ^a   Backman, Steven B ^a   Cecere, Renzo ^a   Lachapelle, Kevin ^a   De Varennes, Benoit ^a   Ergina, Patrick ^a   Metrakos, Peter ^a   Schricker, Thomas ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALLOPURINOL; AMIODARONE; APROTININ; ATORVASTATIN; CARVEDILOL; DOCUSATE SODIUM; FERROUS SULFATE; FRESH FROZEN PLASMA; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; INOTROPIC AGENT; METHYLPREDNISOLONE; METOLAZONE; MIDAZOLAM; NORADRENALIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PANCURONIUM; PANTOPRAZOLE; RAMIPRIL; ROCURONIUM; SEVOFLURANE; SPIRONOLACTONE; SUFENTANIL; UNINDEXED DRUG; VASOACTIVE AGENT; WARFARIN;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ANASTOMOSIS LEAKAGE; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY STENT OCCLUSION; BLEEDING; CARDIOPULMONARY BYPASS; CASE REPORT; COMBINED HEART AND LIVER TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE CIRRHOSIS; CONGESTIVE HEART FAILURE; CONGESTIVE LIVER DYSFUNCTION; CONTINUOUS HEMOFILTRATION; CRYOPRECIPITATE; ERYTHROCYTE CONCENTRATE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FLUID RETENTION; GENERAL ANESTHESIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEPATIC ARTERY; HEPATITIS B; HUMAN; HYPERTROPHIC RESTRICTIVE CARDIOMYOPATHY; HYPOTENSION; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PLASMA TRANSFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RESTRICTIVE CARDIOMYOPATHY; SEPSIS; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TRICUSPID VALVE REGURGITATION; BLOOD GAS ANALYSIS; HEART FAILURE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME;

BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; COMBINED MODALITY THERAPY; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 77953291813     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-010-9263-y     Document Type: Article

References (24)

1. Starzl TE, Bilheimer DW, Bahnson HT, et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382-3.
2. Tazbir JS, Cronin DC 2nd. Indications, evaluations and postoperative care of the combined liver-heart transplant recipient. AACN Clin Issues 1999; 10: 240-52.
3. U.S. Department of Health and Human Services. Multi-Organ Transplants Performed: January 1, 1988 - April 30, 2009. Available from URL: http://optn.transplant.hrsa.gov/ (accessed December 2009).
4. Detry O, Honore P, Meurisse M. Advantages of inferior vena caval flow preservation in combined transplantation of the liver and heart. Transpl Int 1997; 10: 150-1.
5. Gandhi SK, Reyes J, Webber SA, Siewers RD, Pigula FA. Case report of combined pediatric heart-lung-liver transplantation. Transplantation 2002; 73: 1968-9.
6. Nardo B, Beltempo P, Bertelli R, et al. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant Proc 2004; 36: 645-7.
7. Befeler AS, Schiano TD, Lissoos TW, et al. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation 1999; 68: 1423-7.
8. Grazi GL, Cescon M, Salvi F, et al. Combined heart and liver transplantation for familial amyloidotic neurophathy: considerations from the hepatic point of view. Liver Transpl 2003; 9: 986-92.
9. Pirenne J, Verleden G, Nevens F, et al. Combined liver and (heart)-lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. Transplantation 2002; 73: 140-5.
10. Alkofer BJ, Chiche L, Khayat A, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc 2005; 37: 2250-2.
11. Te HS, Anderson AS, Millis JM, Jeevanandam V, Jensen DM. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008; 27: 753-9.
12. Baldry C, Backman SB, Metrakos P, Tchervenkov J, Barkun J, Moore A. Liver transplantation in a Jehovah's Witness with ankylosing spondylitis. Can J Anesth 2000; 47: 642-6.
13. Shan WL, Barkun J, Metrakos P, Tchervenkov J, Backman SB. Blood product use during orthotopic liver transplantation. Can J Anesth 2004; 51: 1045-6.
14. Shaw BW Jr, Bahnson HT, Hardesty RL, Griffith BP, Starzl TE. Combined transplantation of the heart and liver. Ann Surg 1985; 202: 667-72.
15. Offstad J, Schrumpf E, Geiran O, Soreide O, Simonsen S. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transplant 2001; 15: 432-6.
16. Bernier PL, Grenon M, Ergina P, et al. Combined simultaneous heart and liver transplantation with complete cardiopulmonary bypass support. Ann Thorac Surg 2007; 83: 1544-5.
17. Eckhoff DE, Frenette L, Sellers MT, et al. Combined cardiac surgery and liver transplantation. Liver Transpl 2001; 17: 60-1.
18. Axelrod D, Koffron A, DeWolf A, et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl 2004; 10: 1386-90.
19. Kristeller JL, Roslund BP, Stahl RF. Benefits and risks of aprotinin use during cardiac surgery. Pharmacotherapy 2008; 28: 112-24.
20. Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7: 185-94.
21. Warnaar N, Mallett S, de Boer MT, et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1, 043 patients. Am J Transplant 2007; 7: 2378-87.
22. Mangano DT, Tudor IC, Dietzel C. Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-65.
23. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31.
24. Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 2008; 14: 73-80.